Buprenorphine for pain guide for nurse practitioners and PAs

Buprenorphine for Pain: What Nurse Practitioners and PAs Need to Know

David Rosenblum, MD
6 minute read

Listen to article
Audio generated by DropInBlog's Blog Voice AI™ may have slight pronunciation nuances. Learn more

Buprenorphine for pain is one of the most useful and most misunderstood tools available to nurse practitioners and physician assistants. It sits between full opioid agonists and non-opioid therapy, and it changes how many advanced practice providers think about safety, tapering, and chronic pain. This guide explains how buprenorphine works, where it fits, and what to know before you use it.

Why Buprenorphine for Pain Deserves Your Attention

Many patients on long-term full-agonist opioids have pain that is only partly controlled and side effects that keep growing. Others have both chronic pain and opioid use disorder. For these patients, buprenorphine for pain offers an option with a different safety profile than morphine, oxycodone, or hydrocodone. The 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain emphasizes individualized decisions, shared decision-making, and careful risk assessment, and it discusses buprenorphine as part of the treatment of opioid use disorder. Advanced practice providers who understand this drug can make better decisions for these patients.

How Buprenorphine Works

Buprenorphine is a partial agonist at the mu-opioid receptor. It binds with very high affinity, so it displaces many full agonists from the receptor, but it activates the receptor less than a full agonist does. It is also an antagonist at the kappa receptor. Clinically, three features matter most:

  • Ceiling effect on respiratory depression. The risk of respiratory depression rises less steeply with dose than with full agonists. The risk is not zero, especially when combined with benzodiazepines, alcohol, or other sedatives.
  • High receptor affinity and slow dissociation. This gives long duration of action, but it also means a full agonist may be less effective while buprenorphine is on board.
  • Analgesia that is often sufficient. Many patients with chronic pain report meaningful relief, and some also show less opioid-induced hyperalgesia.

Formulations and Indications

Formulation matters, because approved indications differ. As far as current labeling goes, transdermal buprenorphine and buccal film are approved for chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment, when alternatives are inadequate. Injectable buprenorphine has an acute pain indication. Sublingual buprenorphine and buprenorphine-naloxone products are approved for opioid use disorder, and their use for pain is off-label. Always confirm the current prescribing information and your state scope of practice before prescribing.

Buprenorphine for pain and buprenorphine for opioid use disorder are related but not identical treatment goals. Some patients have both conditions. Documenting the diagnosis you are treating, the goals of therapy, and the monitoring plan protects the patient and you.

Who May Be a Candidate

Patients who often come up in discussions of buprenorphine for pain include the following:

  • Patients with chronic pain who have escalating doses of full-agonist opioids with limited functional benefit.
  • Patients with opioid-induced hyperalgesia or intolerable side effects.
  • Patients who need long-term opioid therapy but have higher overdose risk factors, such as older age, renal impairment, or sleep-disordered breathing.
  • Patients with chronic pain and co-occurring opioid use disorder.

Buprenorphine is not right for every patient. Consider allergy or intolerance, hepatic impairment, QT concerns with some formulations, pregnancy planning, concurrent sedatives, and the patient's own goals. When the picture is complicated, collaborate with a pain physician or addiction specialist.

Transitioning From Full Agonists

The main practical challenge is the transition. Because buprenorphine displaces full agonists, starting it too quickly in a patient who is physically dependent can precipitate withdrawal. Approaches include the traditional method, which waits for mild withdrawal, and low-dose or micro-dosing strategies, which overlap small amounts of buprenorphine with the full agonist. Protocols vary by institution and formulation, and they are not a substitute for clinical judgment, so follow your local guidelines and current references rather than any single blog post. Set expectations with the patient about what the first days may feel like, and arrange close follow-up.

Safety, Monitoring, and Documentation

Using buprenorphine for pain does not remove the need for good opioid stewardship. Sound practice includes:

  • Checking the state prescription drug monitoring program and reviewing other sedating medications.
  • Offering naloxone, since overdose risk is lower but not eliminated.
  • Screening for substance use disorders and mental health conditions.
  • Setting functional goals, such as walking, sleeping, or returning to work, and reassessing them at each visit.
  • Documenting informed consent, the indication, the formulation, and the plan for follow-up.

Buprenorphine Around Procedures and Surgery

A common question is what to do when a patient on buprenorphine needs a procedure or surgery. Current perioperative guidance generally favors continuing buprenorphine in most patients and adding multimodal analgesia, including regional anesthesia and non-opioid medications, rather than stopping the drug. This is where interventional skills help. Nerve blocks, ultrasound-guided injections, and regenerative techniques give advanced practice providers more ways to control pain without escalating opioids. Coordinate with the surgeon, anesthesiologist, and prescriber before any change.

Bringing It Into Your Practice

Buprenorphine for pain works best as one part of a broader plan that includes physical therapy, behavioral health, non-opioid medications, and procedures. Advanced practice providers who build skills across all of these areas are better prepared to manage complex pain patients safely. If you are looking for structured training, the Pain Management for Advanced Practice Providers course from NRAP Academy was designed for nurse practitioners and physician assistants who want a practical foundation in pain medicine.

Explore the APP Pain CourseView the Course Calendar

Want a shortcut for pain evaluations?

Download our free Pain Evaluation Checklist for Advanced Practice Providers — a shortcut to hit all the key points when evaluating a pain patient.

Get the Free Evaluation Checklist

Key Takeaways

Buprenorphine is a partial opioid agonist with a ceiling effect on respiratory depression, several formulations, and different approved indications. Buprenorphine for pain requires careful patient selection, thoughtful transitions from full agonists, standard opioid safety measures, and clear documentation. Perioperative continuation is often appropriate. Above all, treat it as part of a multimodal plan and involve specialists when needed. This article is for education only and does not replace clinical judgment or current prescribing information.

Clinicians who are looking for Pain Management Board Prep or CME training in regional anesthesia, ultrasound-guided interventional pain, regenerative pain medicine, or ultrasound-guided IV placement should go to NRAPPain.org. Shadowing, online, private, and group training are available. Email Info@NRAPpain.org for details.

Explore NRAP TrainingListen to the PainExam Podcast

« Back to Blog

Join the NRAP Newsletter!

Add your email to the mailing list to receive discounts, event notifications and more!

Thank You

Board Prep

Question Banks, CME Activities and more!